Published in Nephron on January 01, 1981
Thrombocytopenia in the setting of hemodialysis using biocompatible membranes. Case Rep Med (2012) 0.75
Comparative genomics of Listeria species. Science (2001) 12.94
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
The mitochondrial genome of Arabidopsis thaliana contains 57 genes in 366,924 nucleotides. Nat Genet (1997) 4.63
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Haptoglobin: a natural bacteriostat. Science (1982) 2.23
Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination. J Thromb Haemost (2004) 2.21
Sequence and analysis of chromosome 3 of the plant Arabidopsis thaliana. Nature (2000) 2.17
Effect on blood lipids, coagulation, and fibrinolysis of a fat high in myristic acid and a fat high in palmitic acid. Am J Clin Nutr (1994) 2.12
The nucleotide sequence of Saccharomyces cerevisiae chromosome IV. Nature (1997) 1.92
Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. ECAT Study Group. European Concerted Action on Thrombosis and Disabilities. Circulation (1996) 1.80
An extensive analysis of Y-chromosomal microsatellite haplotypes in globally dispersed human populations. Am J Hum Genet (2001) 1.70
New lessons for combinatorial biosynthesis from myxobacteria. The myxothiazol biosynthetic gene cluster of Stigmatella aurantiaca DW4/3-1. J Biol Chem (1999) 1.49
Multicentre randomised study of computerised anticoagulant dosage. European Concerted Action on Anticoagulation. Lancet (1998) 1.47
A comparison of artificially-depleted, lyophilized coumarin and fresh coumarin plasmas in thromboplastin calibration. European Concerted Action on Anticoagulation. Br J Haematol (1998) 1.44
A simplified statistical method for local INR using linear regression. European Concerted Action on Anticoagulation. Br J Haematol (1997) 1.40
Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol (1991) 1.39
Physical mapping of the mitochondrial genome of Arabidopsis thaliana by cosmid and YAC clones. Plant J (1994) 1.39
The postoperative fibrinolytic shutdown: a rapidly reverting acute phase pattern for the fast-acting inhibitor of tissue-type plasminogen activator after trauma. Scand J Clin Lab Invest (1985) 1.22
copia-, gypsy- and LINE-like retrotransposon fragments in the mitochondrial genome of Arabidopsis thaliana. Genetics (1996) 1.22
Are olive oil diets antithrombotic? Diets enriched with olive, rapeseed, or sunflower oil affect postprandial factor VII differently. Am J Clin Nutr (1999) 1.18
Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris. The ECAT Angina Pectoris Study Group. Arterioscler Thromb (1993) 1.14
The complete nucleotide sequence of the egg drop syndrome virus: an intermediate between mastadenoviruses and aviadenoviruses. Virology (1997) 1.13
Sex hormone-binding globulin as a marker for the thrombotic risk of hormonal contraceptives: a rebuttal. J Thromb Haemost (2013) 1.12
Dependence of energy transduction in intact skeletal muscles on the time in tension. Biophys J (1977) 1.12
Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results: a rebuttal. J Thromb Haemost (2013) 1.10
Break-up of the Atlantic deep western boundary current into eddies at 8 degrees S. Nature (2004) 1.09
Genetic influence on thrombotic risk markers in the elderly--a Danish twin study. J Thromb Haemost (2005) 1.02
Identification of the species origin of highly processed meat products by mitochondrial DNA sequences. PCR Methods Appl (1995) 1.02
An international multicenter randomized study of computer-assisted oral anticoagulant dosage vs. medical staff dosage. J Thromb Haemost (2008) 1.00
European Concerted Action on Anticoagulation (ECAA)-the multicentre calibration of rabbit and human ECAA reference thromboplastins. Steering Committee. Thromb Haemost (1996) 0.96
Elevated fibrinogen and the relation to acute phase response in diabetic nephropathy. Thromb Res (1996) 0.96
Minimum lyophilized plasma requirement for ISI calibration. European Concerted Action on Anticoagulation. Am J Clin Pathol (1998) 0.95
The prothrombin time/international normalized ratio (PT/INR) Line: derivation of local INR with commercial thromboplastins and coagulometers--two independent studies. J Thromb Haemost (2011) 0.94
Fibrin clot formation and lysis: basic mechanisms. Semin Thromb Hemost (2000) 0.94
European Concerted Action on Anticoagulation (ECAA): multicentre international sensitivity index calibration of two types of point-of-care prothrombin time monitor systems. Br J Haematol (2002) 0.93
Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids. Atherosclerosis (1990) 0.92
The effect of low-dose acetylsalicylic acid on bleeding after transurethral prostatectomy--a prospective, randomized, double-blind, placebo-controlled study. Scand J Urol Nephrol (2000) 0.92
European Concerted Action on Anticoagulation (ECAA). An assessment of lyophilised plasmas for ISI calibration of CoaguChek and TAS whole blood prothrombin time monitors. J Clin Pathol (2003) 0.92
Fat high in stearic acid favorably affects blood lipids and factor VII coagulant activity in comparison with fats high in palmitic acid or high in myristic and lauric acids. Am J Clin Nutr (1994) 0.92
The variability of and associations between measures of blood coagulation, fibrinolysis and blood lipids. Atherosclerosis (1992) 0.92
Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb Haemost (1999) 0.91
Coverage of tobacco dependence treatments for pregnant smokers in health maintenance organizations. Am J Public Health (2001) 0.90
The effect of sample size on fresh plasma thromboplastin ISI determination. Br J Haematol (1999) 0.90
European Concerted Action on Anticoagulation--comparison of fresh plasma and whole blood multicentre ISI calibrations of CoaguChek Mini and TAS PT-NC whole blood prothrombin time point-of-care monitors. Thromb Haemost (2002) 0.90
Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost (2003) 0.89
Effect of fish diet versus meat diet on blood lipids, coagulation and fibrinolysis in healthy young men. J Intern Med (1991) 0.88
Post-operative blood loss after transurethral prostatectomy is dependent on in situ fibrinolysis. Br J Urol (1997) 0.88
Low-fat, high-fiber diet favorably affects several independent risk markers of ischemic heart disease: observations on blood lipids, coagulation, and fibrinolysis from a trial of middle-aged Danes. Am J Clin Nutr (1994) 0.88
Effects of different progestin regimens in hormone replacement therapy on blood coagulation factor VII and tissue factor pathway inhibitor. Hum Reprod (2002) 0.87
Mosaic open reading frames in the Arabidopsis thaliana mitochondrial genome. Biol Chem (1997) 0.87
Effect of long-term hormone replacement therapy on tissue factor pathway inhibitor and thrombin activatable fibrinolysis inhibitor in healthy postmenopausal women: a randomized controlled study. J Thromb Haemost (2003) 0.86
Is there gender bias in the prehospital management of patients with acute chest pain? Prehosp Emerg Care (2001) 0.86
The loss of ions from Venus through the plasma wake. Nature (2007) 0.85
A study of the fibrin plate assay of fibrinolytic agents. Optimal conditions, reproducibility and precision. Haemostasis (1983) 0.85
Report on the Dutch consensus development meeting for implementation and further development of population screening for colorectal cancer based on FOBT. Cell Oncol (2005) 0.84
Parenteral anticoagulants in heart disease: current status and perspectives (Section II). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost (2013) 0.84
Favorable long-term effect of a low-fat/high-fiber diet on human blood coagulation and fibrinolysis. Arterioscler Thromb (1993) 0.83
Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet (1995) 0.83
Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study. J Intern Med (2000) 0.83
Genomic recombination of the mitochondrial atp6 gene in Arabidopsis thaliana at the protein processing site creates two different presequences. DNA Res (1996) 0.83
Stage-Specific State I-State II Transitions during the Cell Cycle of Euglena gracilis. Plant Physiol (1986) 0.82
Factor VII polymorphisms in populations with different risks of cardiovascular disease. Arterioscler Thromb Vasc Biol (1997) 0.82
The importance of "like to like" ISI calibrations with freeze dried plasmas. European Concerted Action on Anticoagulation. J Clin Pathol (1998) 0.82
Fasting serum insulin levels and coronary heart disease in a Danish cohort: 17-year follow-up. J Cardiovasc Risk (1995) 0.82
Lupus anticoagulant is significantly associated with inflammatory reactions in patients with suspected deep vein thrombosis. Scand J Clin Lab Invest (2007) 0.81
The European Concerted Action on Anticoagulation (ECAA): field studies of coagulometer effects on the ISI of ECAA thromboplastins. Thromb Haemost (1998) 0.81
The European Concerted Action on Anticoagulation (ECAA) evaluation of a set of lyophilized normal plasmas to establish the normal prothrombin time for coagulometer systems. Thromb Haemost (1998) 0.81
Lack of correlation between blood fibrinolysis and the immediate or post-operative blood loss in transurethral resection of the prostate. Br J Urol (1997) 0.81
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric Study. BJOG (2003) 0.81
The autodigestion of human plasmin follows a bimolecular mode of reaction subject to product inhibition. Thromb Res (1986) 0.81
The clinical evaluation of International Normalized Ratio variability and control in conventional oral anticoagulant administration by use of the variance growth rate. J Thromb Haemost (2013) 0.80
DNA-polymorphisms and plasma levels of vascular disease risk factors in Greenland Inuit--is there a relation with the low risk of cardiovascular disease in the Inuit? Thromb Haemost (1999) 0.80
Effects of dietary fat quality and quantity on postprandial activation of blood coagulation factor VII. Arterioscler Thromb Vasc Biol (1997) 0.80
On the usefulness of fibrinolysis variables in the characterization of a risk group for myocardial reinfarction. Acta Med Scand (1987) 0.80
Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Possible role of the endothelium. J Intern Med (1990) 0.80
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum. Scand J Clin Lab Invest (1995) 0.80
Venous thrombosis after abdominal surgery. A comparison between subcutaneous heparin and antithrombotic stockings, or both. J Med (1988) 0.79
Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost (1994) 0.79
Multicentre evaluation of commercial kit methods: plasminogen activator inhibitor activity. Thromb Haemost (1993) 0.79
Fasting blood coagulation and fibrinolysis of young adults unchanged by reduction in dietary fat content. Arterioscler Thromb (1992) 0.79
Chronic interstitial cystitis: increased levels of eosinophil cationic protein in serum and urine and an ameliorating effect of subcutaneous heparin. Scand J Urol Nephrol (1983) 0.79
Reactive coagulation induced by plasmin in patients treated with recombinant tissue-type plasminogen activator. Coron Artery Dis (1993) 0.79
The influence of desipramine on the sensitivity and accumulation of noradrenaline in the isolated tail artery of the rat. Eur J Pharmacol (1970) 0.79
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives. Contraception (1999) 0.79
Lipoprotein profile of a Greenland Inuit population. Influence of anthropometric variables, Apo E and A4 polymorphism, and lifestyle. Arterioscler Thromb (1992) 0.79
European Concerted Action on Anticoagulation. A multicentre calibration study of WHO international reference preparations for thromboplastin, rabbit (RBT/90) and human (rTF/95). J Clin Pathol (2005) 0.78
Identification of an L-dopa decarboxylase gene from Sorangium cellulosum So ce90. Arch Microbiol (2000) 0.78
European Concerted Action on Anticoagulation (ECAA): an assessment of a method for ISI calibration of two whole blood point-of-care PT monitor systems based on lyophilized plasmas using whole blood equivalent PT. J Thromb Haemost (2003) 0.78
Viral nucleic acid sequence transfer between fungi and plants. Trends Genet (1997) 0.78
European Concerted Action on Anticoagulation (ECAA): International Normalized Ratio variability of CoaguChek and TAS point-of-care testing whole blood prothrombin time monitors. Thromb Haemost (2002) 0.78
Possible role of vascular intima for generation of coagulant activity in patients undergoing coronary thrombolysis with recombinant tissue-type plasminogen activator. A randomized, placebo-controlled study. Scand J Clin Lab Invest (1991) 0.78
Depressed plasma fibrinolytic activity in a group of patients with connective tissue diseases. Scand J Rheumatol (1989) 0.78
Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women. J Thromb Haemost (2003) 0.78
A cDNA clone encoding a 10.8 kDa photosystem I polypeptide of barley. FEBS Lett (1988) 0.78
Enhanced effective fibrinolysis following the neutralization of heparin in open heart surgery increases the risk of post-surgical bleeding. Thromb Haemost (1990) 0.78
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis (1997) 0.78
[Anticoagulant treatment]. Ugeskr Laeger (2000) 0.78
Effects of hormone replacement therapy on hemostatic cardiovascular risk factors. Am J Obstet Gynecol (1999) 0.78
Nursing specialty practice guidelines: the implications for clinical scholarship and early intervention practice. American Nurses' Association. J Pediatr Nurs (1993) 0.78